Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA.
Nat Immunol. 2010 Sep;11(9):836-45. doi: 10.1038/ni.1914. Epub 2010 Aug 1.
BAFF and APRIL are innate immune mediators that trigger immunoglobulin G (IgG) and IgA class-switch recombination (CSR) in B cells by engaging the receptor TACI. The mechanism that underlies CSR signaling by TACI remains unknown. Here we found that the cytoplasmic domain of TACI encompasses a conserved motif that bound MyD88, an adaptor that activates transcription factor NF-kappaB signaling pathways via a Toll-interleukin 1 (IL-1) receptor (TIR) domain. TACI lacks a TIR domain, yet triggered CSR via the DNA-editing enzyme AID by activating NF-kappaB through a Toll-like receptor (TLR)-like MyD88-IRAK1-IRAK4-TRAF6-TAK1 pathway. TACI-induced CSR was impaired in mice and humans lacking MyD88 or the kinase IRAK4, which indicates that MyD88 controls a B cell-intrinsic, TIR-independent, TACI-dependent pathway for immunoglobulin diversification.
BAFF 和 APRIL 是先天免疫介质,通过与受体 TACI 结合在 B 细胞中触发免疫球蛋白 G(IgG)和 IgA 类别转换重组(CSR)。TACI 介导 CSR 信号的机制尚不清楚。在这里,我们发现 TACI 的细胞质结构域包含一个保守的基序,该基序结合了 MyD88,MyD88 是一种衔接蛋白,通过 Toll-白细胞介素 1(IL-1)受体(TIR)结构域激活转录因子 NF-κB 信号通路。TACI 缺乏 TIR 结构域,但通过激活 NF-κB 通过 Toll 样受体(TLR)样 MyD88-IRAK1-IRAK4-TRAF6-TAK1 途径通过 DNA 编辑酶 AID 触发 CSR。缺乏 MyD88 或激酶 IRAK4 的小鼠和人类的 TACI 诱导的 CSR 受损,这表明 MyD88 控制 B 细胞内在的、非 TIR 依赖的、TACI 依赖的免疫球蛋白多样化途径。